Chaoyang Zhu

Statistics

Publications

Citations

233

H-Index

Active since

2017

Affiliations

Henan University Huaihe Hospital and Huaihe Clinical Institute(Current)

Chaoyang Zhu is an author at Henan University Huaihe Hospital and Huaihe Clinical Institute specializing in oncology, molecular oncology, and gene expression.

ORCID

Publications per year

2017–2021

Publications

miR-27b and miR-34a enhance docetaxel sensitivity of prostate cancer cells through inhibiting epithelial-to-mesenchymal transition by targeting ZEB1

Guangwei Zhang, Xin Tian, Yang Li et al. · Biomedicine & Pharmacotherapy · 2017 · 53 citations

Medicine, Cancer Biology, Oncology +15

LncRNA lnc‐ISG20 promotes renal fibrosis in diabetic nephropathy by inducing AKT phosphorylation through miR‐486‐5p/NFAT5

Yurui Duan, Bao‐Ping Chen, Fang Chen et al. · Journal of Cellular and Molecular Medicine · 2021 · 38 citations · Full text

Medicine, Molecular Biology, Nephrology +17

Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p

Wu Huijuan, Xin Tian, Chaoyang Zhu · Cancer Cell International · 2020 · 37 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

<p>LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway</p>

Zhiqiang Wang, Chaowei Zhang, Junkai Chang et al. · OncoTargets and Therapy · 2020 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +17

UCA1 promotes cell proliferation and invasion and inhibits apoptosis through regulation of the miR129&ndash;SOX4 pathway in renal cell carcinoma

Qian Liu, Yang Li, Weiling Lv et al. · OncoTargets and Therapy · 2018 · 25 citations · Full text

Medicine, Molecular Biology, Oncology +17

1–5 of 8